(Q34566668)

3 August 2017

1 reference

title

Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment (English)

1 reference

3 August 2017

Paul A Lapchak

1

1 reference

3 August 2017

1 January 2002

1 reference

Current Neurology and Neuroscience Reports

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

1

1 reference

3 August 2017

38-43

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-002-0051-0

3 August 2017

0 references

cites work

Hemorrhagic transformation in cardioembolic cerebral infarction

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

The Harvard Cooperative Stroke Registry: A prospective registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Thrombolytic stroke therapy: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Thrombolytic therapy in stroke: possibilities and hazards.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Reduction of intracerebral hemorrhaging in a rabbit embolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-002-0051-0

Antioxidants, oxidative stress, and degenerative neurological disorders

21 January 2018

1 reference

12 December 2020

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

12 December 2020

Protective effects of free radical inhibitors in intracerebral hemorrhage in rat.

1 reference

12 December 2020

Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon.

1 reference

12 December 2020

Facilitation of postischemic reperfusion with alpha-PBN: assessment using NMR and Doppler flow techniques.

1 reference

12 December 2020

Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction.

1 reference

12 December 2020

Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia

1 reference

12 December 2020

Blood chemistry changes in the rat induced by high doses of nitronyl free radical spin traps

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.

1 reference

12 December 2020

Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence.

1 reference

12 December 2020

Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat.

1 reference

12 December 2020

Delayed treatment with alpha-phenyl-N-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rat.

1 reference

12 December 2020

Matrix metalloproteinases in brain injury

1 reference

12 December 2020

Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits

1 reference

12 December 2020

Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies.

1 reference

12 December 2020

Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN)

1 reference

12 December 2020

N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia

1 reference

12 December 2020

The clot thickens--thrombolysis and combination therapies.

1 reference

12 December 2020

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke

1 reference

12 December 2020

tPA-associated reperfusion after acute stroke demonstrated by SPECT

1 reference

12 December 2020

Trends and future developments in the pharmacological treatment of acute ischaemic stroke

1 reference

12 December 2020

1 reference

12 December 2020

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

12 December 2020

Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats

1 reference

12 December 2020

Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.

1 reference

12 December 2020

Microvascular responses to cerebral ischemia/inflammation

1 reference

12 December 2020

SM-20302, a nonpeptide GPIIb/IIIa receptor antagonist, exhibits a wide therapeutic window in a newly developed hemorrhage model in mice

1 reference

12 December 2020

Open label tissue plasminogen activator for stroke: The Oregon experience

1 reference

12 December 2020

Hemorrhagic transformation in cerebral embolism

1 reference

12 December 2020

Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-alpha processing.

1 reference

12 December 2020

Reducing bleeding complications after thrombolytic therapy for stroke: clinical potential of metalloproteinase inhibitors and spin trap agents

1 reference

12 December 2020

Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.

1 reference

12 December 2020

Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically induced thrombosis model in guinea pigs

1 reference

12 December 2020

Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors

1 reference

12 December 2020

The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke

1 reference

12 December 2020

Free radical spin traps as adjuncts for the prevention and treatment of disease

1 reference

12 December 2020

Risk-Benefit Of Thrombol Ysis

1 reference

12 December 2020

Free radicals as mediators of neuronal injury.

1 reference

12 December 2020

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

12 December 2020

Calcium and ischemic injury

1 reference

12 December 2020

Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.

1 reference

12 December 2020

Matrix metalloproteinases in cerebrovascular disease

1 reference

12 December 2020

Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue

1 reference

12 December 2020

Mechanisms of secondary brain injury

1 reference

12 December 2020

Excretion, metabolism and tissue distribution of a spin trapping agent, alpha-phenyl-N-tert-butyl-nitrone (PBN) in rats

1 reference

12 December 2020

Characterization of the radical trapping activity of a novel series of cyclic nitrone spin traps

1 reference

12 December 2020

Bleeding complications with platelet glycoprotein IIb/IIIa receptor antagonists.

1 reference

12 December 2020

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

1 reference

12 December 2020

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

12 December 2020

Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors

1 reference

12 December 2020

Glycoprotein IIb/IIIa blockade and thrombolytics: early lessons from the SPEED and GUSTO IV trials

1 reference

12 December 2020

Extracellular matrix-degrading proteinases in the nervous system

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs

1 reference

12 December 2020

Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment

1 reference

12 December 2020

Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model

1 reference

12 December 2020

Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial

1 reference

12 December 2020

Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window

1 reference

12 December 2020

Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

1 reference

12 December 2020

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

1 reference

12 December 2020

10.1007/S11910-002-0051-0

Identifiers

DOI

1 reference

PubMed ID

11898581

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

11898581